-
Mashup Score: 0
Researchers found that age was not associated with recurrence-free survival or overall survival.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Prostate Cancer Overtreatment Persists in Active Surveillance Era - Oncology Nurse Advisor - 2 month(s) ago
Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Even in the active surveillance era, overtreatment persists among men with limited life expectancy and intermediate- to high-risk #prostateCancer, a new study finds. Published in @renalandurology. https://t.co/w6h1USxRms #pcsm
-
-
Mashup Score: 0Nivolumab Plus Ipilimumab Bests Chemo in MSI-H, dMMR Colorectal Cancer - Oncology Nurse Advisor - 2 month(s) ago
Progression-free survival was improved among patients who received nivolumab and ipilimumab, and toxicity was generally greater among patients who received chemotherapy.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The combination of nivolumab and ipilimumab prolongs PFS when compared to chemotherapy in patients with MSI-H or dMMR #colorectalCancer. Published in The @NEJM and @CancerTherAdvsr. https://t.co/CGDIcFpHrj
-
-
Mashup Score: 0Dosing Schedule for Adjuvant Chemo in High-Risk Early Breast Cancer Can Be Patient’s Choice - Oncology Nurse Advisor - 2 month(s) ago
The selection and schedule of treatment should depend on patient preference and toxicity potential, according to Azka Ali, MD.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Patients with high-risk early #breastcancer have similar survival outcomes with different dosing schedules of adjuvant anthracycline- and taxane-based chemotherapy. Presented at @SABCSSanAntonio #SABCS24, reported by @CancerTherAdvsr. https://t.co/oVsL61juOd #bcsm
-
-
Mashup Score: 0Analysis of Nurse Involvement in Germline BRCA Testing Pathways - Oncology Nurse Advisor - 2 month(s) ago
A study of genetic testing pathways identified roles for nurses in counseling, addressing consent, conducting blood tests, and communicating results.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
A new study describes ways in which nurses have a role in the BRCA1/BRCA2 testing process. Reported in @oncologynursing. https://t.co/64b74XoDsT
-
-
Mashup Score: 0Cancer Surgery Ups Survival in the Hemodialysis Population - Oncology Nurse Advisor - 2 month(s) ago
The prognosis of patients diagnosed with cancer after starting hemodialysis appears comparable to that of patients with cancer in the general population.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
In a study of patients diagnosed with cancer after initiating #hemodialysis, the 3-year survival rate was substantially higher among patients treated with surgery than those who were not, according to a recent report. From @renalandurology. https://t.co/3adigSbkXC… https://t.co/g9kFK6Dnhx
-
-
Mashup Score: 0Risk of Cardiac Events Higher With Osimertinib Than With Other TKIs - Oncology Nurse Advisor - 2 month(s) ago
Patients are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, data suggest.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Patients with EGFR-mutant non-small cell #lungcancer are significantly more likely to experience treatment-related cardiac events with osimertinib than with other EGFR TKIs, study results suggest. From @CancerTherAdvsr. https://t.co/P9VK0hkhrV #NSCLC #lcsm
-
-
Mashup Score: 0Belzutifan Plus Cabozantinib: A First-Line Treatment for Advanced RCC? - Oncology Nurse Advisor - 2 month(s) ago
“The results of this first phase 2 study of belzutifan combined with cabozantinib suggest that dual targeting of HIF-2α and VEGF pathways might be an effective first-line treatment strategy in advanced clear-cell renal cell carcinoma,” researchers wrote.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
The combination of belzutifan and cabozantinib has demonstrated “promising” antitumor activity in treatment-naive patients with advanced clear-cell #renalCellCarcinoma. Reported in @TheLancetOncol and @CancerTherAdvsr. https://t.co/Y0HHZuLsCJ #RCC
-
-
Mashup Score: 0Radioiodine Therapy Unnecessary After Thyroidectomy in Low-Risk Thyroid Cancer - Oncology Nurse Advisor - 2 month(s) ago
Researchers conducted a randomized controlled trial to assess the need for postoperative radioiodine therapy among patients with low-risk thyroid cancer.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Postoperative radioiodine administration is unnecessary for patients with low-risk #thyroidcancer. Published in @TheLancetEndo and @EndoAdvisor. https://t.co/3rhl5lKPH8
-
-
Mashup Score: 0Mobile Internet-Based Postop Management Enhanced Patient Experience After Radical Prostatectomy - Oncology Nurse Advisor - 2 month(s) ago
Researchers conducted a retrospective study to determine the effectiveness of internet-based postop care for patients with prostate cancer.
Source: www.oncologynurseadvisor.comCategories: General Medicine News, Oncologists1Tweet-
Use of a mobile internet-based management approach resulted in a better postoperative experience for patients with #prostatecancer who underwent radical prostatectomy. https://t.co/eGtA4eXX4j #pcsm
-
Age may not be a prognostic factor for patients with #cervicalcancer, according to researchers. Published in @CancerTherAdvsr. https://t.co/QTAIIJFdHs #gyncsm